ramfan, I agree with regard to the share BB. They seem to be holding fairly flat with Cash. I know the new major outlier is what will the loss of the 25% of the 1/3 CVS market loss do. Will EU strengthen revs enough to cover the CVS decline?
Will Amarin receive two more EU reimbursement approvals prior to EOY (24),k but we could then assume increasing revs from Europe albeit maybe slow.
Will the Hikma case be sent back for a jury trial? If so, will Hikma be scared s...less about a loss and treble damages regardless of when that might happen, and go ahead and settle?
If we are concerned today about the US market and want to attempt to regain marketshare, why not go ahead with the AG?
So, I am in favor of the share BB which at today's pricing could take 80M shares out of the float which is 20% of the total shares.
Then Sarissa announce additional share purchases which would bolster confidence in the market.
A lot of possibilities but as discussed yesterday, it's very quiet from Sarissa and Amarin and most of us would like more communication as they promised.
JMO
Market Data 
Markets 
AI
